Connecting you to better health
Software enabled therapeutics for enhanced clinical outcomes
A winning combination
Introducing the eFormulation™ Platform
MedicationExisting medication with demonstrated benefit
ApplicationDigital application designed to enhance medication efficacy
eFormulation™Medication and software combined for synergistic clinical effects
eFormulations™: Bridging the Gap Between Clinical and Home Care
The Pear Team
Corey McCann MD, PhD
Founder and Chief Executive Officer
Corey has background as a physician, scientist, entrepreneur, and healthcare investor. Previously, he was an investor with MPM Capital and with RiverVest Venture Partners, where he evaluated new investment opportunities, managed relationships with strategic partners, and oversaw board-level strategy and execution at portfolio companies. Prior to MPM, he was with McKinsey & Company, where he advised pharmaceutical, medical device, and biotechnology companies on the acquisition, development, and commercialization of life science technologies. He also led McKinsey’s Central Nervous System (CNS) expertise group, serving clients across pharma and biotech. He is a founding member of multiple start-ups including Alcyone Lifesciences, a company developing technologies to deliver therapeutics to the brain. Dr. McCann’s post-graduate training was at Harvard University, Washington University in St Louis, and at the Massachusetts General Hospital, and he graduated summa cum laude from The Pennsylvania State University where he was an Evan Pugh Scholar.
Stephen Kennedy Smith JD
Co-founder and Executive Vice President, Corporate Development
Stephen is an entrepreneur, business advisor, and has a long career in the development, funding and expansion of companies. He has served as a director or advisor to several companies, including Gridline Communications Holdings, RAPID Pharmaceuticals, Mainland Resources and, Med-Design Corp. Stephen is also an active member of the Kennedy family financial advisory board. He served as Deputy Campaign Manager for Senator Edward Kennedy during his presidential and senatorial campaigns. And also served on the staff of the Senate Judiciary and Foreign Relations Committees. Stephen taught negotiation at Harvard University Law School and is a three-time winner of Harvard’s Danforth Award for Excellence in Teaching and a recipient of the Lyndehurst Foundation prize for social and artistic achievement. Mr. Kennedy-Smith holds an M.A. from Harvard University, a J.D. from Columbia University, and an M.A. Ed. from Harvard’s School for Education.
William Greene MD
Co-Founder and Medical
Bill has a background as a physician, healthcare investor and entrepreneur. He has been a Venture Partner at MPM Capital, were he has served on the Board of Directors at Intercell, Idun Pharmaceuticals, Barrier Therapeutics, Alnara, Cotherix, and most recently, Sai Advantium. He is also the current President and CEO of Iconic Therapeutics, a company developing novel therapeutics for ophthalmologic diseases. Prior to joining MPM, Bill was at Genentech where he served as a Senior Clinical Scientist and Epidemiologist with responsibilities in clinical strategy, trial design and regulatory affairs. He has also served at Yale Medical School, where he trained in Internal Medicine and Radiology, taught medicine, and conducted clinical research. He has been awarded the Henry Christian Award for outstanding research from the American Federation of Clinical Research and is a Member of the American College of Physicians. Dr. Greene holds an M.D. from UCSF, where he was an Assistant Professor of Medicine and a B.A., Phi Beta Kappa, from Wesleyan University.
Matthew Smith, PhD
Director, Operations & Strategy
Matthew is a scientist, strategic consultant, and mental health advocate. He has held positions at Harvard Medical School and the University of Michigan over the last 7 years, making discoveries around how changes in the brain lead to mental disorders like Alzheimer’s disease and dementia. Matthew received his PhD in Neuropathology and this experience has left him acutely aware of the many hurdles in developing new pharmaceutical agents that can impact brain-related disease. As a consultant, Matthew has a diverse background analyzing the scientific rationale and economic opportunity of novel technologies in oncology, neurology, and anti-infectives, among others. Dr. Smith is a member of the American Association for the Advancement of Science, the American Chemical Society, the Alzheimer’s Association, and the Parkinson’s Action Network, all advocacy groups committed to improving patient outcomes through research.
Arjun Goyal MD, MBA
Director, Corporate Development
Arjun has a background as a physician, entrepreneur and healthcare investor. He is an Associate at 5AM Ventures where he evaluates new investment opportunities and assists portfolio companies. Prior to joining 5AM Ventures, Arjun was co-founder of Foresight Pharmaceuticals, a company developing hormonal treatments for sexually transmitted infections. He trained in internal medicine through the University of Sydney hospital system and is the author of several patents. Earlier in his career, he served as an analyst in global health policy at the Australian Mission to the United Nations. He holds a B.S. in Medical Science, a Diploma in French and an M.D. from the Universities of Melbourne and Oxford, a M. Phil from the University of Cambridge and a MBA from Harvard Business School, where he was a Kaplan Life Science Fellow and an American Australian Association Fellow.
Chief Product Officer
Beth is a media technology professional, transmedia producer and marketing strategist. She was a founding member of the internationally renowned Multimedia Studies Program at SFSU where she taught and published a book on multimedia. She then worked in hardware, software and services at such top firms as Silicon Graphics, Macromedia and the digital agency Circle, (bought by Euro RSCG). Beth has since founded games and apps companies including Signal 2 Productions, Match Factor and D2S Games. She helped produce and publish more than 30 causal games and apps, including apps for health care and wellness. Beth is an advisor to many start-ups including the Mobile Monday Momentum Accelerator, Grimm Bros Games, Major League Wizardry and Digify. In 2011, Beth founded Transmedia SF, an agency/studio/incubator/salon that boasts a community of over 5000 creatives and hosts regular educational and networking events.
Walter Greenleaf, PhD
Chief Science Officer
Walter has a background in both neuroscience research and clinical product development. As a research scientist, Dr. Greenleaf has focused on age-related changes in the human neuroendocrine system, and the effects of hormones on mood and behavior. His PhD is in Neuro- and Bio-Behavioral Sciences, from Stanford University. His most recent academic appointment was as Director for the Mind Division, Stanford Center on Longevity. As a medical product developer, Walter has designed and developed several clinical product streams: his focus has been on the use of simulation and telemedicine technology to treat difficult problems in behavioral and physical medicine. Dr. Greenleaf founded and served as CEO for: Greenleaf Medical Systems, a business incubator; InWorld Solutions, specializing in the therapeutic use of virtual worlds for behavioral health care; and Virtually Better, which develops virtual environments for the treatment of phobias, anxiety disorders, and PTSD.
Chief Technical Officer
Rabah is an entrepreneur, technologist, award-winning mobile game developer and hands-on software architect with over 20 years experience. He started coding at age 13 and founded his first software venture at age 15. Rabah has developed, led and launched software products within small startups and in companies as large as Oracle. He founded successful software ventures in Dubai, Vancouver and Silicon Valley. Rabah was a co-founder of Cosmos Software, a pioneering new media development firm in Dubai, Cosmos was chosen by Dubai government as its strategic partner for Dubai Idea Oasis, Dubai’s first technology incubator. Rabah is also the creator of Babylonian Twins, the No.1 hit mobile game with over 2 million downloads. Babylonian Twins was featured several times by Apple, Google and Microsoft. Before joining Pear, Rabah was a founder of IndieYard, a platform that democratizes mobile app discovery for indie developers. He was also an advisor and consultant for a number of Silicon Valley startups.
Chief of Big Data
Karthik is an entrepreneur and an experienced data scientist. He is also one of the co-founders of LogBase Inc, a company that develops anomaly detection techniques on clickstream data. Previously, he led the machine learning and big data efforts at LinkedIn security team. He is a full-stack data scientist with deep expertise in the complete life cycle of major data-driven systems. He has a Masters degree from Columbia University where his research includes predicting seizures from a patient’s intracranial EEG signals, anomaly detection on network traffic between hosts, and detecting gunshots in an urban environment.
Chair of Advisory Board and Advisor on Healthcare Policy and Reimbursement. Former United States Representative, Rhode Island; Co-Founder of One Mind for Research and Founder; Co-founder of Kennedy Forum
Jeffrey A. Lieberman, MD
Advisor on Pharmacotherapies in Psychiatry. Former President of the American Psychiatric Association; Lawrence C. Kolb Professor and Chairman of Psychiatry at the Columbia University College of Physicians and Surgeons; Director of the New York State Psychiatric Institute.
Advisor on Neurotechnology and Neurogaming. Founder and Executive Director of the Neurotechnology Industry Organization (NIO); Co-founder of NeuroInsights; Founder and Executive Producer of the NeuroGaming Conference
Albert “Skip” Rizzo, PhD
Advisor on Neurosoftware content. Director for Medical Virtual Reality, University of Southern California Institute for Creative Technologies; Research Professor, USC Davis School of Gerontology and USC Keck School of Medicine Department of Psychiatry & Behavioral Sciences
Magali Haas, MD, PhD, MSE
Advisor on pharmaceutical industry partnerships. Founder and CEO, Orion Bionetworks; Chief Science and Technology Officer for One Mind for Research; Developer of beyond the pill strategies for Johnson and Johnson
Eric C. Leuthardt, MD
Advisor on intellectual property. Associate Professor in the Department of Neurological Surgery and the Department of Biomedical Engineering at Washington University in St. Louis; Director of the Center for Innovation in Neuroscience and Technology; Neuroinventor
JoAnn Difede, PhD
Advisor on clinical development. Professor, Department of Psychiatry at Weill Medical College of Cornell University, an Attending Psychologist at the New York-Presbyterian Hospital/Weill Cornell Medical Center; Director of the Program for Anxiety and Traumatic Stress Studies (PATSS)
Alex "Sandy" Pentland, PhD
Advisor on big data strategies. Toshiba Professor of Media Arts and Sciences, MIT Media Lab; Director, MIT Media Lab Entrepreneurship Program
Advisor on Child and Adolescent Psychiatry. President and Co-founder of the Child Mind Institute
Where We Live
Keep in TouchEmail: email@example.com
Or sign up for news and updates: